Barclays Maintains Underweight on Medpace Hldgs, Raises Price Target to $525

Benzinga · 1d ago
Barclays analyst Luke Sergott maintains Medpace Hldgs (NASDAQ:MEDP) with a Underweight and raises the price target from $485 to $525.